Physician

Janice L Gelfand

According to 2025 Medicare claims, Janice Gelfand (NPI: 1316982663) practices neuropsychiatry in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bronx, NY. Gelfand uses personal NPI as billing NPI and primary practice location at 10463-1845.

Gelfand's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 40 traditional Medicare patients, billed 1,339 HCPCS/CPT codes, and received $139,282 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 508 prescription claims across 43 beneficiaries totaling $24,339 in drug costs, led by Mirtazapine (Mirtazapine). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $42,169 to $24,339. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$70K$139K2015 Medicare payment: $113,211 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $113,137 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $112,640 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $113,728 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $110,057 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $100,140 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $122,883 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $117,475 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $137,327 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $139,282 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015701,674$113,211
2016721,699$113,137
2017661,754$112,640
2018771,695$113,728
2019581,557$110,057
2020501,367$100,140
2021451,185$122,883
2022401,183$117,475
2023401,334$137,327
2024401,339$139,282

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$27K$55K2015 Drug cost: $42,169 (USD; Tot_Drug_Cst)2016 Drug cost: $47,029 (USD; Tot_Drug_Cst)2017 Drug cost: $44,272 (USD; Tot_Drug_Cst)2018 Drug cost: $54,728 (USD; Tot_Drug_Cst)2019 Drug cost: $50,197 (USD; Tot_Drug_Cst)2020 Drug cost: $40,004 (USD; Tot_Drug_Cst)2021 Drug cost: $34,707 (USD; Tot_Drug_Cst)2022 Drug cost: $27,970 (USD; Tot_Drug_Cst)2023 Drug cost: $31,634 (USD; Tot_Drug_Cst)2024 Drug cost: $24,339 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201563711$42,169
201662733$47,029
201766788$44,272
201876860$54,728
201962740$50,197
202056711$40,004
202155621$34,707
202247526$27,970
202344542$31,634
202443508$24,339

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more37621$109
90838Psychotherapy with evaluation and management visit, 1 hour38631$100

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MirtazapineMirtazapine181,200$871
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine11330$739
Escitalopram OxalateEscitalopram Oxalate321,920$647
Quetiapine Fumarate ErQuetiapine Fumarate22720$552
Bupropion Hcl SrBupropion Hcl201,020$506

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Janice L. Gelfand?

Tedicare shows public-source Medicare data for Janice L. Gelfand (NPI 1316982663), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Janice L. Gelfand have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Janice L. Gelfand?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Janice L. Gelfand have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.